WEKO3
アイテム
Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas
https://repo.qst.go.jp/records/64433
https://repo.qst.go.jp/records/64433f0288929-cff9-4f95-950e-5f79008f40ef
| Item type | 会議発表用資料 / Presentation(1) | |||||
|---|---|---|---|---|---|---|
| 公開日 | 2011-11-29 | |||||
| タイトル | ||||||
| タイトル | Carbon Ion Radiotherapy for Bone and Soft Tissue Sarcomas | |||||
| 言語 | ||||||
| 言語 | eng | |||||
| 資源タイプ | ||||||
| 資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
| 資源タイプ | conference object | |||||
| アクセス権 | ||||||
| アクセス権 | metadata only access | |||||
| アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
| 著者 |
Imai, Reiko
× Imai, Reiko× Kamada, Tadashi× Tsuji, Hiroshi× Maruyama, Katsuya× Matsumoto, Keiji× Tsujii, Hirohiko× 今井 礼子× 鎌田 正× 辻 比呂志× 丸山 克也× 松本 圭司× 辻井 博彦 |
|||||
| 抄録 | ||||||
| 内容記述タイプ | Abstract | |||||
| 内容記述 | A clinical trial was first initiated in 1996 to evaluate the safety and efficacy of carbon ion radiotherapy for bone and soft tissue sarcomas not suitable for surgery. As of February 2011, a total of 800 patients were enrolled in the clinical trials. Through a dose escalation trial and a subsequent fixed dose trial, it was revealed that carbonion radiotherapy provided definite local control and offered a survival advantage without unacceptable morbidity for patients with bone and soft tissue cancers that were either difficult or impossible to cure using other modalities. | |||||
| 会議概要（会議名, 開催地, 会期, 主催者等） | ||||||
| 内容記述タイプ | Other | |||||
| 内容記述 | 2nd NIRS-ETOILE Joint Symposium on Carbon Ion Therapy | |||||
| 発表年月日 | ||||||
| 日付 | 2011-11-27 | |||||
| 日付タイプ | Issued | |||||
